Literature DB >> 15912882

Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases.

Arie Perry1, Eriks A Lusis, David H Gutmann.   

Abstract

Meningothelial hyperplasia is a poorly characterized entity, often associated with advanced age, chronic renal failure, trauma, hemorrhage, and neoplasia. In order to elucidate the nature of this lesion, 11 cases defined by the presence of nests of 10 or more cell layers thick, were compared with normal arachnoidal cap cells and meningiomas. Immunohistochemistry and FISH were performed to determine NF2 (merlin), protein 4.1B, EMA, progesterone receptor (PR), EGFR, survivin, VEGF, PDGF-BB, PDGFR-beta, E-cadherin, and cathepsin D status. All cases had at least one putative predisposing factor, including hemorrhage (7), chronic renal disease (5), old age (5), trauma (1), and an adjacent optic nerve pilocytic astrocytoma (1). There was typically a discontinuous growth pattern, with no invasion of surrounding normal tissue. No gene deletions were found, though scattered polyploid cells were seen in 2 cases. The immunoprofile was similar to normal cap cells with one exception; whereas normal cells were uniformly negative for PR, nuclear positivity was seen in 64% of hyperplasias, a frequency similar to that of benign meningiomas. Our data suggest that meningothelial hyperplasia is a reactive process that is usually distinguishable from meningioma based on clinicopathologic and genetic features. It may be preneoplastic in some, though further studies are needed to test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912882     DOI: 10.1111/j.1750-3639.2005.tb00505.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  8 in total

Review 1.  Pathological classification and molecular genetics of meningiomas.

Authors:  Christian Mawrin; Arie Perry
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

2.  Intradural Extramedullary Concurrent Schwannoma and Meningothelial Hyperplasia at C2-C3 Cervical Vertebrae: A Case Report and Review of Literature.

Authors:  Rayan Rammal; Daniel F Marker; Rana Naous
Journal:  Case Rep Pathol       Date:  2022-05-05

3.  Dural arachnoid granulations and "giant" arachnoid granulations.

Authors:  Johannes Haybaeck; Rene Silye; Dov Soffer
Journal:  Surg Radiol Anat       Date:  2008-04-08       Impact factor: 1.246

4.  Intradiploic Arachnoid Cyst with Meningothelial Hyperplasia: A Case Report.

Authors:  Hanae Saida; Eiichi Ishikawa; Noriaki Sakamoto; Takuma Hara; Toshitsugu Terakado; Tomohiko Masumoto; Hiroyoshi Akutsu; Makoto Shibuya; Tetsuya Yamamoto; Shingo Takano; Akira Matsumura
Journal:  NMC Case Rep J       Date:  2016-12-05

5.  Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.

Authors:  Michel Kalamarides; Anat O Stemmer-Rachamimov; Masaya Takahashi; Zhi-Yan Han; Fabrice Chareyre; Michiko Niwa-Kawakita; Peter M Black; Rona S Carroll; Marco Giovannini
Journal:  Brain Pathol       Date:  2007-10-09       Impact factor: 6.508

6.  Caspase-3 and survivin expression in primary atypical and malignant meningiomas.

Authors:  Andrej Vranic
Journal:  ISRN Neurosci       Date:  2013-12-19

7.  PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss.

Authors:  Matthieu Peyre; Céline Salaud; Estelle Clermont-Taranchon; Michiko Niwa-Kawakita; Stephane Goutagny; Christian Mawrin; Marco Giovannini; Michel Kalamarides
Journal:  Oncotarget       Date:  2015-10-20

8.  Characterization of a Novel Aspect of Tissue Scarring Following Experimental Spinal Cord Injury and the Implantation of Bioengineered Type-I Collagen Scaffolds in the Adult Rat: Involvement of Perineurial-like Cells?

Authors:  Haktan Altinova; Pascal Achenbach; Moniek Palm; Istvan Katona; Emmanuel Hermans; Hans Clusmann; Joachim Weis; Gary Anthony Brook
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.